RecruitingNot applicableNCT05253872

The MELAcare Study: A New Method for Surveillance of Melanoma Patients

Studying Germ cell tumor

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Herlev and Gentofte Hospital
Principal Investigator
Lisbet R Hölmich, Professor
Herlev and Gentofte Hospital
Intervention
The MelaCare intervention(other)
Enrollment
378 target
Eligibility
18 years · All sexes
Timeline
20222028

Study locations (1)

Collaborators

Danish Cancer Society

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05253872 on ClinicalTrials.gov

Other trials for Germ cell tumor

Additional recruiting or active studies for the same condition.

See all trials for Germ cell tumor

← Back to all trials